FDA Urges Supreme Court to Hear Abortion Pill Access Case

The US Court of Appeals for the Fifth Circuit was wrong when it ruled the FDA’s regulations over abortion drug mifepristone should be rolled back, the agency said in a reply supporting its request that the US Supreme Court hear the case.

In a reply brief filed Tuesday, US Solicitor General Elizabeth Prelogar, on behalf of the Food and Drug Administration, asked the Supreme Court to grant its request for review.

The filing comes after the FDA asked the high court for review in September after the Fifth Circuit found the FDA’s regulations allowing mifepristone to be mailed, taken later ...